LYRA (Lyra Therapeutics) Future Price to Earnings

Official company branding of Lyra Therapeutics (LYRA)

Lyra Therapeutics, Inc. (LYRA) relies on outsourcing research and production to third-party vendors for its operational efficiency. The company's forward P/E ratio on the GURU.Markets chart illustrates how the market values its strategy for implementing biodegradable implants for ENT organs, with the indicator reaching 0.00. However, the current pipeline restructuring following failed tests creates significant risks for the asset's future capitalization.

lyratherapeutics.com - LYRA Market Cap to Future Earnings Ratio (period 07/04/2022 - 03/28/2026)

Summary analytical data breakdowns for lyratherapeutics.com (LYRA)

- current price and projected stock value:
Fundamental valuation:LYRA Lyra Therapeutics, Inc
Brand item of Lyra Therapeutics, Inc.

The market views the prospects of Lyra Therapeutics, Inc. (LYRA) skeptically due to failed clinical trials and a lack of stable revenue streams. The relationship between the current price and expected earnings, as illustrated by the company's forward P/E trend, reflects speculative optimism rather than fundamental value, as the cash burn transforms this indicator into a marker of high risk for a total asset write-down.

Competing companies

Future Price to Earnings haleon.com (HLN)|KVUE (Kenvue Health) - Future Price to Earnings Multiple|Future Price to Earnings Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Projected Price to Earnings Ratio|LGND: Projected Price to Earnings|Amneal - Market Cap to Future Earnings Ratio|PRGO: Forward P/E Multiple|Alvotech Corp - Future Price to Earnings Multiple|LQDA (Liquidia Corp) - Forward P/E Multiple|Projected Price to Earnings Ratio glpg.com GLPG|Future Price to Earnings ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Future Price to Earnings Multiple|Forward P/E Multiple AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Price to Expected Earnings Ratio|SPRY - Future Price to Earnings|Future Price to Earnings Multiple TBPH (Theravance Biopharma)|AQST (aquestive.com) - Projected Price to Earnings|Price to Expected Earnings Ratio SCPH (scPharmaceuticals, Inc.)|Projected Price to Earnings TECX|Tonix Pharmaceuticals (TNXP) - Market Cap to Projected Earnings|Forward P/E Multiple SXTC|Forward P/E Multiple Eupraxia Pharma (EPRX)|Future Price to Earnings BioHarvest Sciences Inc. BHST|EXOZ - Projected Price to Earnings|ORMP: Projected Price to Earnings|Future Price to Earnings Multiple ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Future Price to Earnings|Projected Price to Earnings Ratio abvcpharma.com (ABVC)|Future Price to Earnings Cumberland Pharma|Future Price to Earnings QNTM|Forward P/E Multiple FGEN|TELO (Telomir Pharma) - Future Price to Earnings Multiple|Future Price to Earnings Rani Therapeutics Holdings RANI|SNYR - Projected Price to Earnings|RLYB - Future Price to Earnings|Market Cap to Projected Earnings lexariabioscience.com LEXX|PULM: Forward P/E Multiple|Price to Future Earnings Ratio PTHL|Future Price to Earnings Aptorum Group Limited|Projected Price to Earnings Impact BioMedical Inc (IBO)|Forward P/E Multiple TNFA|YCBD: Price to Expected Earnings Ratio|Future Price to Earnings PainReform PRFX|altamiratherapeutics.com (CYTO) - Projected Price to Earnings Ratio|LIPO: Projected Price to Earnings|OPTN (optinose.com) - Price to Future Earnings Ratio|PIRS: Forward P/E Multiple|PROC - Market Cap to Projected Earnings|PTPI (Petros Pharma) - Forward P/E Multiple|Future Price to Earnings QLI|Forward P/E Multiple SLRN|Market Cap to Future Earnings Ratio TFFP